Author:
Nicoli Sara,Bunge Annette L.,Delgado-Charro M. Begoña,Guy Richard H.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Organic Chemistry,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biotechnology
Reference30 articles.
1. HHS, FDA, and CDER. Topical dermatological drug product NDAs and ANDAs—in vivo bioavailability, bioequivalence, in vitro release and associated studies Draft Guidance for Industry. (1998).
2. Y. N. Kalia, I. Alberti, A. Naik, and R. H. Guy. Assessment of topical bioavailability in vivo: the importance of stratum corneum thickness. Skin Pharmacol Appl Skin Physiol. 14(Suppl 1):82–86 (2001) doi: 10.1159/000056394 .
3. L. K. Pershing, J. L. Nelson, J. L. Corlett, S. P. Shrivastava, D. B. Hare, and V. P. Shah. Assessment of dermatopharmacokinetic approach in the bioequivalence determination of topical tretinoin gel products. J Am Acad Dermatol. 48:740–751 (2003) doi: 10.1067/mjd.2003.175 .
4. M. B. Reddy, A. L. Stinchcomb, R. H. Guy, and A. L. Bunge. Determining dermal absorption parameters in vivo from tape strip data. Pharm Res. 19:292–298 (2002) doi: 10.1023/A:1014443001802 .
5. V. P. Shah. IV-IVC for topically applied preparations—a critical evaluation. Eur J Pharm Biopharm. 60:09–14 (2005) doi: 10.1016/j.ejpb.2004.09.015 .
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献